• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patients.

作者信息

Gonella M, Ballanti P, Della Rocca C, Calabrese G, Pratesi G, Vagelli G, Mazzotta A, Bonucci E

机构信息

Servizio di Nefrologia e Dialisi, Ente Ospedaliero, Casale Monferrato, Italia.

出版信息

Miner Electrolyte Metab. 1988;14(4):240-5.

PMID:3211092
Abstract

The dialysate magnesium concentration (dMg) was reduced from 1 to 0.5 mEq/l in a group of patients on chronic hemodialysis (RDT). Serum parameters and bone biopsy findings were evaluated before and after a 1-year period on the lower dMg. All patients were receiving only calcium carbonate before and during the study period. Serum magnesium (sMg) decreased significantly and fell in the normal range with low dMg, whereas the other serum parameters did not change significantly except serum phosphorous which increased, still remaining within the normal limits. Furthermore, a significant reduction of the osteomalacia pattern (evaluated by osteoid volume, osteoid surface and osteoid thickness index) was observed in all patients after 1 year on dMg of 0.5 mEq/l, whereas there was no significant variation in bone resorption patterns (resorption surface and osteoclasts). Therefore, normal sMg is recommended in RDT patients, by arranging their dMg according to individual need, in the hypothesis that high bone Mg content, attributed to hypermagnesemia, could interfere with the mineralization process.

摘要

相似文献

1
Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patients.
Miner Electrolyte Metab. 1988;14(4):240-5.
2
Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.不同透析液的血液透析患者透析期间血清镁的变化及其与低血压发作的关系。
Hemodial Int. 2006 Oct;10 Suppl 2:S16-23. doi: 10.1111/j.1542-4758.2006.00120.x.
3
Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.降低透析液钙浓度对血液透析患者血清骨转换标志物的影响。
Bone. 2005 May;36(5):909-16. doi: 10.1016/j.bone.2005.02.008. Epub 2005 Mar 24.
4
The effects of zero magnesium dialysate and magnesium supplements on ionised calcium concentration in patients on regular dialysis treatment.
Nephrol Dial Transplant. 1987;2(5):347-50.
5
[Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].[慢性血液透析期间铝中毒导致的骨软化症]
Arch Fr Pediatr. 1982 Dec;39 Suppl 2:749-54.
6
[Bone disorders in children with chronic renal insufficiency exposed to high ingestion of aluminum].[慢性肾功能不全儿童因大量摄入铝而导致的骨骼疾病]
Bol Med Hosp Infant Mex. 1990 May;47(5):336-41.
7
Low serum aluminum values in dialysis patients with increased bone aluminum levels.骨铝水平升高的透析患者血清铝值较低。
Clin Nephrol. 1998 Aug;50(2):69-76.
8
Satisfactory control of secondary hyperparathyroidism with low-calcium dialysate in patients not receiving vitamin D.在未接受维生素D治疗的患者中,使用低钙透析液对继发性甲状旁腺功能亢进进行满意控制。
Miner Electrolyte Metab. 1997;23(1):19-24.
9
Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis.接受血液透析或腹膜透析患者的血清离子镁缺乏。
ASAIO J. 1993 Jul-Sep;39(3):M801-4.
10
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.

引用本文的文献

1
Magnesium and Vascular Calcification in Chronic Kidney Disease: Current Insights.镁与慢性肾脏病血管钙化:最新研究进展。
Int J Mol Sci. 2024 Jan 18;25(2):1155. doi: 10.3390/ijms25021155.
2
Magnesium and Fracture Risk in the General Population and Patients Receiving Dialysis: A Narrative Review.普通人群及接受透析治疗患者中的镁与骨折风险:一项叙述性综述
Can J Kidney Health Dis. 2023 Feb 17;10:20543581231154183. doi: 10.1177/20543581231154183. eCollection 2023.
3
Magnesium Administration in Chronic Kidney Disease.镁在慢性肾脏病中的应用。
Nutrients. 2023 Jan 20;15(3):547. doi: 10.3390/nu15030547.
4
The emerging role of magnesium in CKD.镁在慢性肾脏病中的新作用。
Clin Exp Nephrol. 2022 May;26(5):379-384. doi: 10.1007/s10157-022-02182-4. Epub 2022 Jan 25.
5
Magnesium to prevent kidney disease-associated vascular calcification: crystal clear?镁预防与肾病相关的血管钙化:前景明朗?
Nephrol Dial Transplant. 2022 Feb 25;37(3):421-429. doi: 10.1093/ndt/gfaa222.
6
The Role of Disturbed Mg Homeostasis in Chronic Kidney Disease Comorbidities.镁稳态紊乱在慢性肾脏病合并症中的作用
Front Cell Dev Biol. 2020 Nov 12;8:543099. doi: 10.3389/fcell.2020.543099. eCollection 2020.
7
Diabetes Mellitus Modifies the Associations of Serum Magnesium Concentration With Arterial Calcification and Stiffness in Incident Hemodialysis Patients.糖尿病会改变血清镁浓度与新发血液透析患者动脉钙化和僵硬之间的关联。
Kidney Int Rep. 2019 Mar 13;4(6):806-813. doi: 10.1016/j.ekir.2019.03.003. eCollection 2019 Jun.
8
Hypomagnesemia is not an independent risk factor for mortality in Japanese maintenance hemodialysis patients.低镁血症不是日本维持性血液透析患者死亡的独立危险因素。
Int Urol Nephrol. 2019 Jun;51(6):1043-1052. doi: 10.1007/s11255-019-02073-w. Epub 2019 Apr 11.
9
Magnesium: A Magic Bullet for Cardiovascular Disease in Chronic Kidney Disease?镁:慢性肾脏病心血管疾病的“万能子弹”?
Nutrients. 2019 Feb 22;11(2):455. doi: 10.3390/nu11020455.
10
Routine hemodialysis induces a decline in plasma magnesium concentration in most patients: a prospective observational cohort study.常规血液透析会使大多数患者的血浆镁浓度下降:一项前瞻性观察性队列研究。
Sci Rep. 2018 Jul 6;8(1):10256. doi: 10.1038/s41598-018-28629-x.